Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 15.4 million follow-on offering of American Depositary Shares (ADSs) and warrants of BioLineRx Ltd. on the NASDAQ Capital Market.
BioLineRx is a clinical-stage bio-pharmaceutical company focused on oncology and immunology.
Oppenheimer & Co. acted as sole book-running manager for the offering. Maxim Group acted as co-manager for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Neta Peled (Associate).